BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 2483977)

  • 1. Immunotherapy as an adjuvant to surgery in carcinoma of bronchus. Results in three randomised trials.
    Roeslin N; Dumont P; Morand G; Wihlm JM; Witz JP
    Eur J Cardiothorac Surg; 1989; 3(5):430-5. PubMed ID: 2483977
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adjuvant immunotherapy with BCG in squamous cell bronchial carcinoma.
    Jansen HM; The TH; Orie NG
    Thorax; 1980 Oct; 35(10):781-7. PubMed ID: 7466726
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Four-year follow-up on the Albany experience with intrapleural BCG in lung cancer.
    McKneally MF; Maver C; Lininger L; Kausel HW; McIlduff JB; Older TM; Foster ED; Alley RD
    J Thorac Cardiovasc Surg; 1981 Apr; 81(4):485-92. PubMed ID: 7009993
    [TBL] [Abstract][Full Text] [Related]  

  • 4. BCG plus levamisole following irradiation of advanced squamous bronchial carcinoma.
    Pines A
    Int J Radiat Oncol Biol Phys; 1980 Aug; 6(8):1041-2. PubMed ID: 7419462
    [No Abstract]   [Full Text] [Related]  

  • 5. [Significance of immunotherapy as an adjunct to surgical treatment in non-small cell carcinoma of the lung].
    Fujisawa T
    Gan To Kagaku Ryoho; 1985 Jan; 12(1):13-20. PubMed ID: 2981513
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immune modulators as antiviral agents.
    Steele RW; Charlton RK
    Clin Lab Med; 1987 Dec; 7(4):911-24. PubMed ID: 2446821
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Attempt at immunotherapy with living BCG in patients with bronchus carcinoma.
    Pouillart P; Palangie T; Huguenin P; Morin P; Gautier H; Baron A; Mathé G
    Recent Results Cancer Res; 1978; 68():260-7. PubMed ID: 752864
    [No Abstract]   [Full Text] [Related]  

  • 8. Trial of BCG immunotherapy in the treatment of resectable sequamous cell carcinoma of the bronchus (stages I and II).
    Pouillart P; Mathé G; Palangie T; Schwarzenberg L; Huguenin P; Morin P; Gautier H; Baron A
    Recent Results Cancer Res; 1977; (62):151-5. PubMed ID: 341247
    [No Abstract]   [Full Text] [Related]  

  • 9. Intrapleural BCG in operable lung cancer.
    Lowe J; Iles PB; Shore DF; Langman MJ; Baldwin RW
    Lancet; 1980 Jan; 1(8158):11-4. PubMed ID: 6101353
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adjuvant immunotherapy with BCG in squamous-cell bronchial carcinoma. Immune-reactivity in relation to immunostimulation (preliminary results in a controlled trial).
    Jansen HM; The TH; de Gast GC; Esselink MT; van der Wal AM; Orie NG
    Thorax; 1978 Aug; 33(4):429-38. PubMed ID: 358479
    [No Abstract]   [Full Text] [Related]  

  • 11. Immunologic alterations and active aspecific immunotherapy in lung cancer patients.
    Banna P; Murabito R; Saggio A; Cordopatri F; Riggi M; Campo ME; Cinà C; Latteri S
    Ital J Surg Sci; 1983; 13(2):133-7. PubMed ID: 6195126
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preliminary results of combined surgery and adjuvant Bacillus Calmette-Guérin plus levamisole treatment of resectable lung cancer.
    Wright PW; Hill LD; Peterson AV; Pinkham R; Johnson L; Ivey T; Bernstein I; Bagley C; Anderson R
    Cancer Treat Rep; 1978 Nov; 62(11):1671-5. PubMed ID: 215304
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Immunotherapy today. II. Immunostimulating therapy].
    D'Amelio R
    Riv Med Aeronaut Spaz; 1978; 41(1):75-114. PubMed ID: 93770
    [No Abstract]   [Full Text] [Related]  

  • 14. [Negative results of a randomized therapeutic trial of nonspecific immunotherapy in primary, surgically-treated non-small cell bronchial cancer].
    Decroix G; Chastang C; Lebeau B; Fabre C; Lepage T; Rebishung JL; Babo P; Fichet D; Soubrane C; Asselain B
    Rev Mal Respir; 1984; 1(1):25-30. PubMed ID: 6379784
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complications of intrapleural BCG in the treatment of operable non-small-cell bronchial carcinoma.
    Law MR; Lam WK; Studdy PR; Pugsley WB; Hodson ME
    Br J Dis Chest; 1982 Apr; 76(2):151-6. PubMed ID: 7093133
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A placebo-controlled randomized double-blind study of adjuvant intrapleural BCG in patients with resected T1N0, T1N1, or T2N0 squamous cell carcinoma, adenocarcinoma, or large cell carcinoma of the lung. LCSG Protocol 771.
    Gail MH
    Chest; 1994 Dec; 106(6 Suppl):287S-292S. PubMed ID: 7988246
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of inoperable non-small cell carcinoma of the lung with radiation therapy, with or without levamisole. A randomized trial of the Southeastern Cancer Study group.
    Krauss S; Comas F; Perez C; Gordon D; Philpott G; Broun G; Mill W; Robbins R; Smalley R; Mendiondo O
    Am J Clin Oncol; 1984 Oct; 7(5):405-12. PubMed ID: 6391141
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of immunostimulating agents on viral infections.
    Zerial A; Werner GH
    Acta Microbiol Acad Sci Hung; 1981; 28(3):325-37. PubMed ID: 6171144
    [No Abstract]   [Full Text] [Related]  

  • 19. Adjuvant immunotherapy in colorectal cancer.
    Vermorken JB
    Semin Oncol; 2000 Oct; 27(5 Suppl 10):66-71. PubMed ID: 11049049
    [No Abstract]   [Full Text] [Related]  

  • 20. Regional immunotherapy of lung cancer with intrapleural B.C.G.
    McKneally MF; Maver C; Kausel HW
    Lancet; 1976 Feb; 1(7956):377-9. PubMed ID: 55646
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.